Axys Pharmaceuticals


Public list: Pharma Startups (4732) Cancer Therapeutics (1137)

Axys Pharmaceuticals, formerly Arris Pharmaceuticals, develops a protease-inhibitor based products for cancer and inflammatory diseases.

Axys Pharmaceuticals, formerly Arris Pharmaceuticals, develops a protease-inhibitor based products for cancer and inflammatory diseases.

Company (Acquired)

Phone:

Fax:

180 Kimball Way

South San Francisco, 94080
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Axys Pharmaceuticals $0M Jun 13, 2001

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Axys Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Cathepsin cysteine protease inhibitors Oct 11, 2012 Jul 08, 2014 Patent
Cathepsin cysteine protease inhibitors May 25, 2011 Nov 27, 2012 Patent
Cathepsin cysteine protease inhibitors Apr 08, 2008 Jul 05, 2011 Patent
Cathepsin cysteine protease inhibitors May 20, 2014 Application